Biogen Inc (BIIB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2005 | 12-2004 | 12-2003 | 12-2002 | 12-2001 | |
| Sales | 2,422,500 | 2,211,562 | 679,183 | 404,222 | 272,677 |
| Cost of Goods | 373,614 | 554,319 | 284,739 | 1,457 | N/A |
| Gross Profit | 2,048,886 | 1,657,243 | 394,444 | 402,765 | 272,677 |
| Operating Expenses | 1,813,460 | 1,614,146 | 1,264,852 | 189,346 | 141,540 |
| Operating Income | 236,040 | 43,416 | -869,669 | 213,876 | 131,137 |
| Other Income | 20,155 | 20,677 | -10,955 | 17,646 | 30,467 |
| Pre-tax Income | 256,195 | 64,093 | -880,624 | 231,522 | 161,604 |
| Income Tax | 95,484 | 39,007 | -5,527 | 83,432 | 59,945 |
| Net Income Continuous | 160,711 | 25,086 | -875,097 | 148,090 | 101,659 |
| Net Income | $160,711 | $25,086 | $-875,097 | $148,090 | $101,659 |
| EPS Basic Total Ops | 0.48 | 0.07 | -4.92 | 0.95 | 0.67 |
| EPS Basic Continuous Ops | 0.48 | 0.07 | -4.92 | 0.97 | 0.67 |
| EPS Diluted Total Ops | 0.47 | 0.07 | -4.92 | 0.85 | 0.59 |
| EPS Diluted Continuous Ops | 0.47 | 0.07 | -4.92 | 0.84 | 0.56 |
| EBITDA(a) | $638,248 | $482,851 | $-808,361 | $224,032 | $137,443 |